PharmaCorp Rx Inc. (TSXV:PCRX)
| Market Cap | 88.78M +57.2% |
| Revenue (ttm) | 20.89M +260.6% |
| Net Income | -1.48M |
| EPS | -0.01 |
| Shares Out | 174.08M |
| PE Ratio | n/a |
| Forward PE | 51.00 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 26,241 |
| Open | 0.5300 |
| Previous Close | 0.5100 |
| Day's Range | 0.5000 - 0.5300 |
| 52-Week Range | 0.4000 - 0.5800 |
| Beta | -4.30 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jun 3, 2026 |
About PharmaCorp Rx
PharmaCorp Rx Inc. operates retail pharmacies under the PharmaChoice name in Canada. The company offers prescription services; front-of-store retail, such as convenience goods, over-the-counter medications, health products, and wellness items; custom compounding; specialized consultations; and lifestyle programs. PharmaCorp Rx Inc. was incorporated in 2021 and is headquartered in Saskatoon, Canada. [Read more]
Financial Performance
In 2025, PharmaCorp Rx's revenue was 20.89 million, an increase of 260.57% compared to the previous year's 5.79 million. Losses were -1.48 million, 46.3% more than in 2024.
Financial StatementsNews
PharmaCorp Rx Registration statement: Q1 2026
PharmaCorp Rx filed a registration statement on June 1, 2026, providing details about a securities offering with the SEC.
PharmaCorp Rx Registration statement: Q1 2026
PharmaCorp Rx filed a registration statement on June 1, 2026, providing details about a securities offering with the SEC.
PharmaCorp Rx Earnings release: Q1 2026
PharmaCorp Rx released its Q1 2026 earnings on June 1, 2026, summarizing the period's financial results.
PharmaCorp Rx Slides: Investor presentation
PharmaCorp Rx has posted slides in relation to its latest quarterly earnings report, which was published on May 6, 2026.
PharmaCorp Rx Earnings release: Q4 2025
PharmaCorp Rx released its Q4 2025 earnings on April 29, 2026, summarizing the period's financial results.
PharmaCorp Rx Transcript: 2026 Bloom Burton & Co. Healthcare Investor Conference
At the 2026 Bloom Burton Healthcare Investor Conference, a pharmacy roll-up firm detailed its exclusive acquisition pipeline, flexible exit options for owners, and focus on operational stability and top-line growth. Recent capital raised will fund further expansion and team growth.
PharmaCorp Rx Earnings release: Q3 2025
PharmaCorp Rx released its Q3 2025 earnings on November 27, 2025, summarizing the period's financial results.
PharmaCorp Rx Slides: Q3 2025
PharmaCorp Rx has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on November 27, 2025.
PharmaCorp Rx Earnings release: Q2 2025
PharmaCorp Rx released its Q2 2025 earnings on August 15, 2025, summarizing the period's financial results.
PharmaCorp Rx Slides: Q2 2025
PharmaCorp Rx has posted slides in relation to its Q2 2025 quarterly earnings report, which was published on August 15, 2025.